Pharma Mar (XMAD:PHM) Other Long-Term Liabilities : €21.5 Mil (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Pharma Mar Other Long-Term Liabilities?

Pharma Mar's other long-term liabilities for the quarter that ended in Mar. 2024 was €21.5 Mil.

Pharma Mar's quarterly other long-term liabilities declined from Sep. 2023 (€27.8 Mil) to Dec. 2023 (€22.3 Mil) and declined from Dec. 2023 (€22.3 Mil) to Mar. 2024 (€21.5 Mil).

Pharma Mar's annual other long-term liabilities declined from Dec. 2021 (€68.8 Mil) to Dec. 2022 (€45.1 Mil) and declined from Dec. 2022 (€45.1 Mil) to Dec. 2023 (€22.3 Mil).

Pharma Mar Other Long-Term Liabilities Historical Data

The historical data trend for Pharma Mar's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Mar Other Long-Term Liabilities Chart

Pharma Mar Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Get a 7-Day Free Trial

Pharma Mar Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Pharma Mar Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Pharma Mar Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Pharma Mar's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharma Mar (XMAD:PHM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Mar SA (XMAD:PHM) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

PHMMF:USA PHMe:UK 0RC6:UK

Address

Avenida de los Reyes, 1, Poligono Industrial La Mina-norte, Colmenar Viejo, Madrid, ESP, 28770

Website

http://www.pharmamar.com

Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and market insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology, Diagnostics, Consumer chemicals, and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.